Skip to main content
OpenTrials

Clinical trial condition

Neurodegenerative Diseases

Explore clinical trials studying Neurodegenerative Diseases. Study availability and eligibility vary by location and protocol.

8,965 public trials 1,748 recruiting studies
Refine in advanced search Browse all conditions

Neurodegenerative Diseases trial results

Recruiting

Treatment of Inflammatory Myelitis and Optic Neuritis With Early vs Rescue Plasma Exchange (TIMELY-PLEX)

NCT07100990

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Central Nervous System Diseases, +20 more
Locations
  • Mayo Clinic Arizona Scottsdale, Arizona, United States
  • Loma Linda University Loma Linda, California, United States
  • University of California, Davis Sacramento, California, United States
  • University of Colorado - Anschutz Medical Aurora, Colorado, United States
View all 33 locations
View Trial Details
Recruiting

A Study to Investigate the Safety and Pharmacodynamics of a Single Intrathecal Injection (IT) of INS1202 in Participants With Amyotrophic Lateral Sclerosis (ALS)

NCT07290062

Conditions
Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +8 more
Locations
  • USA004 La Jolla, California, United States
  • USA002 Palo Alto, California, United States
  • USA001 Columbia, Missouri, United States
  • USA007 Columbus, Ohio, United States
View Trial Details
Recruiting

A Study Evaluating the Effectiveness and Safety of Risdiplam Administered as an Early Intervention in Pediatric Participants With Spinal Muscular Atrophy After Gene Therapy

NCT05861986

Conditions
Central Nervous System Diseases, Motor Neuron Disease, Muscular Atrophy, Spinal, +4 more
Locations
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • Children's Hospital of Colorado Aurora, Colorado, United States
  • University of Florida Pediatrics Gainesville, Florida, United States
  • Children's Healthcare of Atlanta Center for Advanced Pediatrics Atlanta, Georgia, United States
View all 16 locations
View Trial Details
Recruiting

A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease

NCT07174310

Conditions
Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +7 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Barrow Neurological Institute Phoenix, Arizona, United States
  • Neurology Center of North Orange County Fullerton, California, United States
  • UC San Diego La Jolla, California, United States
View all 174 locations
View Trial Details

Related conditions